Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,271,961 papers from all fields of science
Search
Sign In
Create Free Account
amfenac
Known as:
2-amino-3-benzoylbenzeneacetic acid, monosodium salt, monohydrate
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Phenylacetates
Narrower (1)
amfenac monosodium salt
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide‐induced ocular inflammation
C. Bucolo
,
G. Marrazzo
,
C. Platania
,
G. L. Romano
,
F. Drago
,
S. Salomone
The Journal of pharmacy and pharmacology
2014
Corpus ID: 1633898
To evaluate the effects of topical non‐steroidal anti‐inflammatory drugs (NSAIDs) on retinal vascular leakage, and inflammatory…
Expand
2014
2014
Melatonin and amfenac modulate calcium entry, apoptosis, and oxidative stress in ARPE-19 cell culture exposed to blue light irradiation (405 nm)
Mehmet Argun
,
L. Tok
,
A. C. Uğuz
,
Ömer Çelik
,
Ozlem Tok
,
Mustafa Nazıroğlu
Eye
2014
Corpus ID: 21550766
PurposeUnder conditions of oxidative stress, cell apoptosis is triggered through the mitochondrial intrinsic pathway. Increased…
Expand
Review
2013
Review
2013
Nepafenac: An Ophthalmic Nonsteroidal Antiinflammatory Drug for Pain After Cataract Surgery
B. M. Jones
,
Michael W. Neville
The Annals of Pharmacotherapy
2013
Corpus ID: 5964094
OBJECTIVE: To examine the efficacy of nepafenac in the treatment of pain and inflammation in patients after cataract surgery…
Expand
2009
2009
Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress.
Nirupama Lal
,
J. Kumar
,
+4 authors
J. Yanni
Archives of Biochemistry and Biophysics
2009
Corpus ID: 7256640
Highly Cited
2008
Highly Cited
2008
Topical ophthalmic NSAIDs: a discussion with focus on nepafenac ophthalmic suspension
B. Gaynes
,
Anne N. Onyekwuluje
Clinical Ophthalmology
2008
Corpus ID: 622163
The removal of diclofenac sodium ophthalmic solution as a viable pharmaceutical entity in September 1999 from the US market…
Expand
2008
2008
Amfenac increases the radiosensitivity of uveal melanoma cell lines
B. Fernandes
,
J. Marshall
,
+4 authors
M. N. Burnier
Eye
2008
Corpus ID: 33896530
PurposeTo evaluate the proliferation rates of five human uveal melanoma (UM) cell lines after treatment with amfenac, a…
Expand
Highly Cited
2007
Highly Cited
2007
In vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenac
Tom Walters
,
M. Raizman
,
P. Ernest
,
J. Gayton
,
R. Lehmann
Journal of cataract and refractive surgery
2007
Corpus ID: 12919251
Highly Cited
2000
Highly Cited
2000
Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: II. In Vitro Bioactivation and Permeation of External Ocular Barriers
T. Ke
,
G. Graff
,
J. Spellman
,
J. Yanni
Inflammation
2000
Corpus ID: 23846950
Nepafenac, the amide analog of the NSAID amfenac, was examined in vitro for its bioactivation by ocular tissue components and its…
Expand
1990
1990
Antiinflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid.
D. A. Walsh
,
H. W. Moran
,
+4 authors
G. Graff
Journal of Medicinal Chemistry
1990
Corpus ID: 207224600
A series of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid (amfenac) and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid…
Expand
1986
1986
Analgesic Efficacy of Amfenac, Aspirin and Placebo After Extraction of Impacted Teeth
Adesh K. Jain
,
Clay C. Hunley
,
J. Kuebel
,
F. Mcmahon
,
Jerome J. Ryan
Pharmacotherapy
1986
Corpus ID: 24034995
Amfenac, an arylacetic acid derivative, is a new investigational, nonsteroidal antiinflammatory agent that has exhibited…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE